{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:03:00Z","timestamp":1793520180809,"version":"4.5.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Shared decision-making is an approach where physicians and patients work together to determine a personalized treatment course. Such an approach is integral to patient-centered care in chronic rhinosinusitis with nasal polyps (CRSwNP). CRSwNP is a chronic inflammatory condition of the sinonasal cavity that can severely impact physical health, smell, and quality of life (QOL). Traditional standard-of-care treatment options include topical (i.e. sprays) and oral corticosteroids and endoscopic sinus surgery, but more recently, novel corticosteroid delivery methods (i.e. high volume irrigations, recently-approved exhalation breath-powered delivering devices, and drug-eluting steroid implants) and 3 new FDA approved biologics directed against type II immunomodulators have become available. The availability of these therapeutics offers exciting new opportunities in CRSwNP management but requires personalized and shared-decision making as each modality has variable impacts on CRSwNP and related comorbid conditions. Studies have published treatment algorithms, but the practical use of these lean guidelines is heavily influenced by the lens of the treating physician, the most common being otolaryngologists and allergy immunologists. Clinical equipoise occurs when there is no basis for one intervention to be regarded as \u201cbetter\u201d than another. While most guidelines, in general, support the use of topical corticosteroids with or without oral corticosteroids followed by ESS for the majority of unoperated CRSwNP patients, there are situations of clinical equipoise that arise particularly in CRSwNP who have failed surgery or those with severe comorbid conditions. In the shared decision-making process, clinicians and patients must consider symptomatology, goals, comfort, compliance, treatment efficacy, and treatment cost when determining the initial choice of therapy and escalation of therapy with the potential use of multiple modalities for recalcitrant CRSwNP. A summary of salient considerations that might constitute shared decision-making is presented in this summary.<\/jats:p>","DOI":"10.3389\/falgy.2023.1137907","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:28:53Z","timestamp":1678408133000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps"],"prefix":"10.3389","volume":"4","author":[{"given":"Shreya P.","family":"Ramkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Miglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/alr.22309","article-title":"Symptom importance, patient expectations, and satisfaction in chronic rhinosinusitis","volume":"9","author":"Mattos","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/0194599818756814","article-title":"Evidence-Based medicine in otolaryngology part 7: introduction to shared decision making","volume":"158","author":"Ikeda","year":"2018","journal-title":"Otolaryngol Head Neck Surg (United States)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2147\/PPA.S85528","article-title":"Empowerment, motivation, and medical adherence (EMMA): the feasibility of a program for patient-centered consultations to support medication adherence and blood glucose control in adults with type 2 diabetes","volume":"9","author":"Varming","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"B4","first-page":"1423","article-title":"Effective physician-patient communication and health outcomes: a review","volume":"152","author":"Stewart","year":"1995","journal-title":"CMAJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/alr.22851","article-title":"Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps","volume":"11","author":"Han","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4193\/RHIN20.601","article-title":"Executive summary of EPOS 2020 including integrated care pathways","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.anl.2021.03.008","article-title":"Evaluation of the literature surrounding shared decision-making in elective rhinological surgery: a scoping review","volume":"48","author":"Karadaghy","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"B9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1377\/hlthaff.2012.1078","article-title":"Shared decision making: examining key elements and barriers to adoption into routine clinical practice","volume":"32","author":"L\u00e9gar\u00e9","year":"2013","journal-title":"Health Aff"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031763","article-title":"Key components of shared decision making models: a systematic review","volume":"9","author":"Bomhof-Roordink","year":"2019","journal-title":"BMJ Open"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1179\/106698111X12899036752014","article-title":"Clinical equipoise and personal equipoise: two necessary ingredients for reducing bias in manual therapy trials","volume":"19","author":"Cook","year":"2011","journal-title":"J Man Manip Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0272989X08327067","article-title":"Decisional conflict in patients and their physicians: a dyadic approach to shared decision making","volume":"29","author":"LeBlanc","year":"2009","journal-title":"Med Decis Mak"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/alr.22633","article-title":"Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from an NIH sponsored workshop","author":"Roland","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA J Am Med Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/all.13823","article-title":"Medical algorithm: diagnosis and treatment of chronic rhinosinusitis","volume":"75","author":"Bachert","year":"2020","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/0194599820931455","article-title":"Intranasal corticosteroid therapy: systematic review and meta-analysis of reported safety and adverse effects in adults","volume":"163","author":"Donaldson","year":"2020","journal-title":"Otolaryngol Head Neck Surg (United States)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060897","article-title":"Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs","volume":"12","author":"De Corso","year":"2022","journal-title":"J Pers Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/00016480600672667","article-title":"Adrenal suppression and osteoporosis after treatment of nasal polyposis","volume":"126","author":"Bonfils","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2500\/ajra.2010.24.3445","article-title":"Prevalence of metabolic bone disease among chronic rhinosinusitis patients treated with oral glucocorticoids","volume":"24","author":"Rajasekaran","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/aje\/153.11.1089","article-title":"Steroids and risk of upper gastrointestinal complications","volume":"153","author":"Hern\u00e1ndez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper [published correction appears in clin transl allergy. 2020 sep 28;10:38]","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jaci.2022.07.023","article-title":"Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis","volume":"150","author":"Bognanni","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/alr.22141","article-title":"EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis","volume":"8","author":"Palmer","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4193\/Rhin19.124","article-title":"EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps","volume":"58","author":"Sher","year":"2020","journal-title":"Rhinology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/alr.22084","article-title":"A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps","volume":"8","author":"Kern","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/03007995.2021.2022874","article-title":"Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery","volume":"38","author":"Hoffman","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/alr.23044","article-title":"Indications for absorbable steroid-eluting sinus implants: viewpoint via the delphi method","volume":"12","author":"Lee","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/alr.21416","article-title":"Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series","volume":"4","author":"Matheny","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/alr.20020","article-title":"Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent","volume":"1","author":"Murr","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/0145561320964653","article-title":"The role of biologics in chronic rhinosinusitis with nasal polyps","volume":"100","author":"Patel","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaip.2020.11.034","article-title":"Biologics for treatment of atopic dermatitis: current Status and future prospect","volume":"9","author":"Ratchataswan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaip.2020.11.043","article-title":"Biologics for the use in chronic spontaneous Urticaria: when and which","volume":"9","author":"Maurer","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-022-00171-2","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life","volume":"20","author":"Nettis","year":"2022","journal-title":"Clin Mol Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaci.2021.10.029","article-title":"Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"149","author":"Scadding","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-021-00493-2","article-title":"Canadian Rhinology working group consensus statement: biologic therapies for chronic rhinosinusitis","volume":"50","author":"Thamboo","year":"2021","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0019-5154.160490","article-title":"Omalizumab-A review","volume":"60","author":"Godse","year":"2015","journal-title":"Indian J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103615","article-title":"Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: a systematic review","volume":"43","author":"Aldajani","year":"2022","journal-title":"Am J Otolaryngol Head Neck Med Surg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1002\/lary.21446","article-title":"Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience","volume":"121","author":"Stankiewicz","year":"2011","journal-title":"Laryngoscope"},{"key":"B43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/alr.20101","article-title":"Nationwide incidence of major complications in endoscopic sinus surgery","volume":"2","author":"Ramakrishnan","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00405-013-2652-4","article-title":"Risks and medico-legal aspects of endoscopic sinus surgery: a review","volume":"271","author":"Re","year":"2014","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0145561320967727","article-title":"A scholarly review of the safety and efficacy of intranasal corticosteroids preparations in the treatment of chronic rhinosinusitis","volume":"100","author":"Macias-Valle","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011993.pub2","article-title":"Different types of intranasal steroids for chronic rhinosinusitis","volume":"2016","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0385-8146(03)00051-8","article-title":"The effectiveness of steroid treatment in nasal polyposis","volume":"30","author":"Tuncer","year":"2003","journal-title":"Auris Nasus Larynx"},{"key":"B48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/alr.22093","article-title":"Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery","volume":"8","author":"Harvey","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/MLG.0b013e31818208c1","article-title":"Pre-And postoperative sinus penetration of nasal irrigation","volume":"118","author":"Grobler","year":"2008","journal-title":"Laryngoscope"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/lary.21092","article-title":"Effect of head position and surgical dissection on sinus irrigant penetration in cadavers","volume":"120","author":"Singhal","year":"2010","journal-title":"Laryngoscope"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100131","article-title":"Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps","volume":"13","author":"Xu","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/alr.21072","article-title":"Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations","volume":"3","author":"Poetker","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/alr.22573","article-title":"Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II","volume":"10","author":"Soler","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/01455613221088698","article-title":"The effect of EDS-FLU on objective and patient-reported subjective outcomes for patients with chronic rhinosinusitis with nasal polyps","author":"Ow","year":"2022","journal-title":"Ear, Nose Throat J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/alr.21309","article-title":"Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study","volume":"4","author":"Lavigne","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/alr.21741","article-title":"RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study","volume":"6","author":"Forwith","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/alr.21426","article-title":"RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis","volume":"4","author":"Han","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/1945892419850924","article-title":"In-office placement of mometasone furoate Sinus implants for recurrent nasal polyps: a pooled analysis","volume":"33","author":"Stolovitzky","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000519228","article-title":"Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis","volume":"183","author":"Wu","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/alr.22780","article-title":"Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Hopkins","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047344","article-title":"Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Wu","year":"2021","journal-title":"BMJ Open"},{"key":"B67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3906\/sag-1912-62","article-title":"Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study","volume":"50","author":"Yilmaz","year":"2020","journal-title":"Turkish J Med Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.iac.2004.09.005","article-title":"Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires","volume":"25","author":"Bender","year":"2005","journal-title":"Immunol Allergy Clin North Am"},{"key":"B70","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1164\/ajrccm\/149.2_Pt_2.S69","article-title":"Measuring adherance to asthma medication regiments","volume":"149","author":"Rand","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0269-4","article-title":"Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis","volume":"9","author":"Calus","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/alr.22146","article-title":"Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype","volume":"8","author":"Miglani","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1945892420961964","article-title":"Surgery in nasal polyp patients: outcome after a Minimum observation of 10 years","volume":"35","author":"Vlaminck","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"B74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/alr.23059","article-title":"A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis","volume":"13","author":"Miglani","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23059","article-title":"Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps","volume":"13","author":"Bhattacharyya","year":"2013","journal-title":"Laryngoscope"},{"key":"B76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s0736-4679(00)00256-0","article-title":"Cost comparison of bronchodilator delivery methods in emergency department treatment of asthma","volume":"19","author":"Frei","year":"2000","journal-title":"J Emerg Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s41669-020-00198-8","article-title":"A corticosteroid-eluting Sinus implant following endoscopic Sinus surgery for chronic rhinosinusitis: a UK-based cost-effectiveness analysis","volume":"4","author":"Javanbakht","year":"2020","journal-title":"PharmacoEconomics Open"},{"key":"B78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/0194599814533779","article-title":"Economic evaluation of a steroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis","volume":"151","author":"Rudmik","year":"2014","journal-title":"Otolaryngol - Head Neck Surg (United States)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"510","DOI":"10.18553\/jmcp.2019.25.5.510","article-title":"The effectiveness and value of biologic therapies for the treatment of uncontrolled asthma","volume":"25","author":"Tice","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/lary.25180","article-title":"Cost of adult chronic rhinosinusitis: a systematic review","volume":"125","author":"Smith","year":"2015","journal-title":"Laryngoscope"},{"key":"B81","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.anai.2019.01.018","article-title":"Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: to biologic or not to biologic?","volume":"122","author":"Anderson","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1002\/lary.28648","article-title":"Cost utility analysis of dupilumab versus endoscopic Sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2021","journal-title":"Laryngoscope"},{"key":"B83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/0194599818763600","article-title":"Evidence-based medicine in otolaryngology, part 8: shared decision making\u2014impact, incentives, and instruments","volume":"159","author":"Ikeda","year":"2018","journal-title":"Otolaryngol Head Neck Surg (United States)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1377\/hlthaff.2011.0941","article-title":"Enhanced support for shared decision making reduced costs of care for patients with preference-sensitive conditions","volume":"32","author":"Veroff","year":"2013","journal-title":"Health Aff"},{"key":"B85","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1188\/19.CJON.540-542","article-title":"Shared decision making: improving patient outcomes by understanding the benefits of and barriers to effective communication","volume":"23","author":"Faiman","year":"2019","journal-title":"Clin J Oncol Nurs"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjsurg.2018.01.011","article-title":"Association of shared decision-making on patient-reported health outcomes and healthcare utilization","volume":"216","author":"Hughes","year":"2018","journal-title":"Am J Surg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pec.2011.07.020","article-title":"Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases","volume":"87","author":"Eckman","year":"2012","journal-title":"Patient Educ Couns"},{"key":"B88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.pec.2005.08.002","article-title":"Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions","volume":"61","author":"Kiesler","year":"2006","journal-title":"Patient Educ Couns"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pon.907","article-title":"Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer","volume":"15","author":"Hack","year":"2006","journal-title":"Psychooncology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1377\/hlthaff.2011.0576","article-title":"Authoritarian physicians and patients\u2019 fear of being labeled \u201cdifficult\u201d among key obstacles to shared decision making","volume":"31","author":"Frosch","year":"2012","journal-title":"Health Aff"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001431.pub5","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"2017","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.otc.2017.03.006","article-title":"The role of patients: shared decision-making","volume":"50","author":"Beers","year":"2017","journal-title":"Otolaryngol Clin North Am"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e21389","DOI":"10.1097\/MD.0000000000021389","article-title":"Interventions to facilitate shared decision-making using decision aids with patients in primary health care: a systematic review","volume":"99","author":"Coronado-V\u00e1zquez","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B94","year":""},{"key":"B95","year":""}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1137907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:28:57Z","timestamp":1678408137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1137907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":95,"alternative-id":["10.3389\/falgy.2023.1137907"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1137907","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1137907"}}